Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis and Parkinson's disease.

Nirit Lev1, Eldad Melamed, Daniel Offen

  • 1Neurosciences Laboratory, Department of Neurology, Felsenstein Medical Research Center, Sackler School of Medicine, Rabin Medical Center, Beilinson Campus, 49100, Petach Tikva, Israel.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|March 27, 2003
PubMed
Summary

Parkinson's disease involves the loss of dopaminergic neurons, with evidence suggesting apoptosis plays a key role. Understanding this cell death mechanism is crucial for developing neuroprotective treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular vesicles from stem cells rescue cellular phenotypes and behavioral deficits in SHANK3-associated ASD neuronal and mouse models.

Cell death & disease·2026
Same author

Migraine epidemiology, comorbidities and therapeutic landscape: a national population-based study.

Frontiers in neurology·2026
Same author

Mesenchymal stem cell-derived exosomes mitigate amyloid β-induced retinal toxicity: Insights from rat model and cellular studies.

Journal of extracellular biology·2025
Same author

Risk factors for actinic keratosis, non-melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross-sectional study.

Skin health and disease·2024
Same author

A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson's disease.

Frontiers in molecular neuroscience·2024
Same author

Efficacy of therapy by MK-28 PERK activation in the Huntington's disease R6/2 mouse model.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2024

Area of Science:

  • Neurodegenerative diseases
  • Cellular and molecular neuroscience

Background:

  • Parkinson's disease (PD) is a progressive neurodegenerative disorder.
  • It results from the loss of dopaminergic neurons in the substantia nigra (SN).
  • The exact cause of PD remains unknown, and current treatments are symptomatic.

Purpose of the Study:

  • To investigate the role of apoptosis in the cell death of nigrostriatal dopaminergic neurons in Parkinson's disease.
  • To determine the mode of cell death in PD to explore potential neuroprotective strategies.

Main Methods:

  • Morphological studies in cell cultures and animal models of PD.
  • Molecular studies in cell cultures and animal models of PD.
  • Analysis of postmortem brain tissue from Parkinson's disease patients.

Related Experiment Videos

Main Results:

  • Evidence indicates that apoptotic cell death occurs in Parkinson's disease.
  • A proapoptotic environment is present in the nigrostriatal region of PD patients.
  • Morphological and molecular data support the involvement of apoptosis.

Conclusions:

  • Apoptosis is a significant mode of cell death in Parkinson's disease.
  • Identifying apoptosis as the cell death mechanism is vital for developing antiapoptotic therapies.
  • Targeting apoptosis may offer a way to protect neurons and slow PD progression.